Brought to you by 
Loxo Oncology goes public, nets $71.4mm
05 Sep 2014
Executive Summary
Loxo Oncology Inc. (cancer therapeutics firm launched last year by Aisling Capital) netted $71.4mm in its initial public offering of 5.9mm common shares (including partial exercise of the overallotment) at $13. The company filed in June, and in mid-July announced that it planned to sell 4.4mm shares for between $12-14.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Loxo Oncology goes public, nets $71.4mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice